The field of pulmonary hypertension has been transformed by advances in understanding of pathophysiological mechanisms and the development of a wide range of therapeutic options. The five main groups of pulmonary hypertension differ in epidemiology, causes and risk factors, underlying disease mechanisms, and clinical presentation. Approaches to diagnosis and management reflect the distinctive features of each condition. In the first of a Series of three papers, Marc Humbert and colleagues provide an